Waters Co. (WAT) Stake Lessened by Seaward Management Limited Partnership
Seaward Management Limited Partnership lowered its stake in shares of Waters Co. (NYSE:WAT) by 3.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,235 shares of the medical instruments supplier’s stock after selling 675 shares during the quarter. Seaward Management Limited Partnership’s holdings in Waters were worth $3,812,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of WAT. Oppenheimer Asset Management Inc. increased its holdings in shares of Waters by 0.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock valued at $105,000 after acquiring an additional 2 shares in the last quarter. ETF Managers Group LLC acquired a new position in shares of Waters during the second quarter valued at about $106,000. Intellectus Partners LLC increased its holdings in shares of Waters by 4.9% during the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock valued at $123,000 after acquiring an additional 31 shares in the last quarter. First Manhattan Co. acquired a new position in shares of Waters during the second quarter valued at about $130,000. Finally, Edmond DE Rothschild Holding S.A. acquired a new position in shares of Waters during the second quarter valued at about $160,000. Hedge funds and other institutional investors own 91.82% of the company’s stock.
Several research firms have recently issued reports on WAT. Bank of America Corporation upped their price objective on shares of Waters from $192.00 to $202.00 and gave the company a “neutral” rating in a report on Friday, November 10th. Cowen and Company restated a “hold” rating and set a $190.00 price objective on shares of Waters in a report on Friday, November 3rd. Zacks Investment Research downgraded shares of Waters from a “buy” rating to a “hold” rating in a report on Thursday, October 26th. Citigroup Inc. restated a “neutral” rating and set a $180.00 price objective on shares of Waters in a report on Wednesday, October 25th. Finally, Barclays PLC upped their price objective on shares of Waters from $188.00 to $193.00 and gave the company an “equal weight” rating in a report on Wednesday, October 25th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $193.62.
In other news, SVP Rohit Khanna sold 26,913 shares of the firm’s stock in a transaction that occurred on Friday, October 27th. The shares were sold at an average price of $197.93, for a total transaction of $5,326,890.09. Following the sale, the senior vice president now owns 13,677 shares of the company’s stock, valued at approximately $2,707,088.61. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Elizabeth B. Rae sold 12,000 shares of the firm’s stock in a transaction that occurred on Friday, November 3rd. The stock was sold at an average price of $197.95, for a total transaction of $2,375,400.00. Following the sale, the senior vice president now directly owns 18,129 shares in the company, valued at approximately $3,588,635.55. The disclosure for this sale can be found here. Insiders have sold a total of 57,313 shares of company stock worth $11,120,642 in the last ninety days. Corporate insiders own 5.07% of the company’s stock.
Shares of Waters Co. (NYSE:WAT) traded up $4.76 during trading hours on Friday, reaching $199.60. 364,900 shares of the company traded hands, compared to its average volume of 519,849. Waters Co. has a one year low of $133.35 and a one year high of $199.83. The company has a current ratio of 6.16, a quick ratio of 5.71 and a debt-to-equity ratio of 0.66. The firm has a market cap of $15,790.00, a P/E ratio of 27.06, a PEG ratio of 2.83 and a beta of 0.82.
Waters (NYSE:WAT) last issued its quarterly earnings data on Tuesday, October 24th. The medical instruments supplier reported $1.77 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.03. The business had revenue of $565.58 million for the quarter, compared to analysts’ expectations of $555.25 million. Waters had a net margin of 24.06% and a return on equity of 21.21%. The business’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company earned $1.57 EPS. research analysts anticipate that Waters Co. will post 7.42 EPS for the current year.
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.